Meeting
2014 ASCO Annual Meeting
Comparison of chemosensitivity testing of CETCs and spheroids in cancer patients with solid tumors.
Authors
Katharina Pachmann
Transfusion Center Bayreuth, Bayreuth, Germany
Katharina Pachmann , Dorothea Zimon , Monika Pizon , Ulrich A. Pachmann
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics - Clinical Pharmacology and Experimental Therapeutics
Track
Developmental Therapeutics
Sub Track
Pharmacology
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 2598)
DOI
10.1200/jco.2014.32.15_suppl.2598
Abstract #
2598
Poster Bd #
61
Abstract Disclosures
Similar Posters
Poster
2014 Breast Cancer Symposium
In vitro chemosensitivity testing of mammospheres cultured from circulating epithelial tumor cells (CETCs) of breast cancer patients: Comparision to chemosensitivity of total CETCs.
First Author: Monika Pizon
Poster
2023 ASCO Annual Meeting
Final results from phase I study of PSCA-targeted chimeric antigen receptor (CAR) T cells in patients with metastatic castration resistant prostate cancer (mCRPC).
First Author: Tanya B. Dorff
Poster
2022 ASCO Annual Meeting
Efficacy and safety of dexamethasone-based mouthwash to prevent chemotherapy-induced stomatitis in women with breast cancer: A multicenter, open-label, randomized phase II study.
First Author: Shigeto Maeda
Poster
2020 ASCO Virtual Scientific Program
GAIN-2: Neo-/adjuvant phase III trial to compare intense dose-dense chemotherapy (CT) to tailored dose-dense CT in patients (pts) with high risk early breast cancer (EBC): Results on safety and interim invasive disease-free survival (iDFS).
First Author: Volker Moebus